These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
3. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672 [TBL] [Abstract][Full Text] [Related]
5. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt. Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450 [TBL] [Abstract][Full Text] [Related]
6. Novel approaches to overcome Colistin resistance in Acinetobacter baumannii: Exploring quorum quenching as a potential solution. Khoshbakht R; Panahi S; Neshani A; Ghavidel M; Ghazvini K Microb Pathog; 2023 Sep; 182():106264. PubMed ID: 37474078 [TBL] [Abstract][Full Text] [Related]
7. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility. Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655 [TBL] [Abstract][Full Text] [Related]
8. In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia. Ku NS; Lee SH; Lim YS; Choi H; Ahn JY; Jeong SJ; Shin SJ; Choi JY; Choi YH; Yeom JS; Yong D; Song YG; Kim JM Sci Rep; 2019 Nov; 9(1):17127. PubMed ID: 31748527 [TBL] [Abstract][Full Text] [Related]
9. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period. Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896 [TBL] [Abstract][Full Text] [Related]
10. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232 [TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [TBL] [Abstract][Full Text] [Related]
12. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture. Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052 [TBL] [Abstract][Full Text] [Related]
13. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii. Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains]. Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401 [TBL] [Abstract][Full Text] [Related]
15. Colistin-induced structural and biochemical changes in carbapenem-resistant Acinetobacter baumannii isolated from the hospital environment. Kadaikunnan S; Alharbi N J Infect Public Health; 2023 Dec; 16 Suppl 1():26-32. PubMed ID: 37980240 [TBL] [Abstract][Full Text] [Related]
16. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473 [TBL] [Abstract][Full Text] [Related]
17. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. Liang W; Liu XF; Huang J; Zhu DM; Li J; Zhang J BMC Infect Dis; 2011 Apr; 11():109. PubMed ID: 21521536 [TBL] [Abstract][Full Text] [Related]